ACT

APR.18/2017


news roundup

MedNet Introduces Updated Cloud Platform

MedNet Solutions eClinical solution, iMedNet, now leverages Amazon Web Services, as well as ClearDATA's security and infrastructure services.


advertisment

Planning Gene Therapy Research? Prepare for institutional biosafety committee (IBC) Review with these tips from the Biosafety Officer at a leading IRB.
LEARN MORE


YPrime Release New eCOA

YPrime has released its data-driven electronic clinical outcome assessment (eCOA) technology platform to capture endpoints from multiple modalities and streamline patient data collection for clinical trials.


TrialScope Launches Global Compliance Tool

TrialScope has launched ATLAS Global Compliance, a software-as-a-service (SaaS) solution that provides sponsors the ability to track and manage global clinical trial disclosure compliance.


advertisment

Webinar: Choose the Right Sites, Gain Insights from Predictive Analytics.
Need to cut your patient enrollment time?
Learn how one sponsor cut time to reach target enrollment by 20% using objective data insights.Find out how you can reduce risk, decrease cost and improve site selection decisions now.
Register today


Accenture, BioCelerate Collaborate on Preclinical Platform

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform allowing its member companies to aggregate and analyze preclinical and clinical information.


Experts Back Randomized Trials for Pandemic Outbreaks

Because of difficulties and delays in trying to design and implement trials during a dangerous and spreading epidemic, experts recommend globally that research authorities address important logistical, ethical and policy issues in advance of the next outbreak.


advertisment

Use Challenge Trials Effectively in Clinical Studies: Lessons Learned from H3N2 Influenza Virus
On Demand
LEARN MORE

advertisment

In this edition

Experts Back Randomized Trials for Pandemic Outbreaks
A Right-Sized Approach to Real-World Studies
The Novartis View of Clinical Trial Patient Centricity
Accenture, BioCelerate Collaborate on Preclinical Platform

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


advertisment

Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
Live Webinar: Tuesday, May 2 at 11:00am EDT
Register now


Events

3rd Annual Endpoint Adjudication
4th Annual eSource Data in Clinical Investigations Bootcamp
Search Upcoming Events

advertisment

Is Your CTMS Working for You? Unify and Optimize Your Approach to Clinical Trials
Live Webcast: Wednesday, April 26 at 1:00pm EDT
Register now


Articles

A Right-Sized Approach to Real-World Studies

The growing interest from regulatory authorities underscores the value that observational studies bring to our understanding of how a drug is used post-marketing, allowing biopharma companies to evaluate clinical results in a real-world setting and validate the safety and efficacy of their products.


The Regulatory Debate Around Pre-approval Product Access

This peer-reviewed article looks at the ethical dilemmas that lawmakers, constitutional scholars, industry representatives, patient advocacy groups and patients themselves face over where to draw the line between regulation for the benefit of society and respect for individual autonomy.

Blog Posts

The Novartis View of Clinical Trial Patient Centricity

Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing at Novartis, delves into how biopharmaceutical enterprises are incorporating digital strategy into patient centric study execution.


advertisment

Improving Clinical Trial Transparency, Collaboration and Efficiencies
On Demand
LEARN MORE


Drug Research Gets a Blip of EU Attention

The newly-established European Reference Networks (ERN) received a prize for its work to connect patients with rare disease experts across the continent.


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Mike Tessalone
Publisher
Michael.Tessalone@ubm.com